...
首页> 外文期刊>Journal of Biomolecular Structure and Dynamics >Evaluation of (?6-p-cymene) ruthenium diclofenac complex as anticancer chemotherapeutic agent: interaction with biomolecules, cytotoxicity assays
【24h】

Evaluation of (?6-p-cymene) ruthenium diclofenac complex as anticancer chemotherapeutic agent: interaction with biomolecules, cytotoxicity assays

机译:评价(α6-yymene)钌双氯芬酸络合物作为抗癌化学治疗剂:与生物分子的相互作用,细胞毒性测定

获取原文
获取原文并翻译 | 示例
           

摘要

The designing of metal-based anticancer therapeutic agents can be optimized in a better and rapid way if the ligands utilized have standalone properties. Therefore, even when the organometallic/coordination complex (i.e., metallodrug) gets dissociated in extreme conditions, the ligand can endorse its biological properties. Herein, we have synthesized and characterized ?6-p-cymene ruthenium diclofenac complex. Furthermore, the ruthenium complex interactions with human serum albumin (HSA) and ct-DNA have been studied using various spectroscopic studies viz., UV, fluorescence, and circular dichroism and exhibited a significant binding propensity. Furthermore, in vitro cytotoxicity assays were carried out against human breast cancer “MCF-7” cell line. The ?6-p-cymene ruthenium diclofenac complex registered significant cytotoxicity with an IC50 value of ~25.0 μM which is comparable to the standard drugs. The ?6-p-cymene ruthenium diclofenac complex was able to decrease the MCF-7 cell proliferation and induced significant levels of apoptosis with relatively low toxicity.
机译:如果使用的配体具有独立性质,可以以更好快速的方式优化基于金属的抗癌治疗剂的设计。因此,即使当有机金属/配位复合物(即,Metallodrug)在极端条件下解离时,配体也能够赞同其生物学性质。在此,我们已经合成并表征了α6-p-cymene钌双氯氟芬酸络合物。此外,使用各种光谱研究VIZ研究了与人血清白蛋白(HSA)和CT-DNA的钌配合物相互作用,紫外,荧光和圆形二色性,并表现出显着的结合倾向。此外,对体外细胞毒性测定进行针对人乳腺癌“MCF-7”细胞系进行。 α6-p-cymene钌双氯芬酸甲酸二甲酸甲酰基复合物注册了显着的细胞毒性,IC 50值为〜25.0μm,其与标准药物相当。 α6-p-cyhene钌双氯氟乙烯络合物能够降低MCF-7细胞增殖,并诱导具有相对低毒性的显着水平的细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号